Innovative research from Mount Sinai has also identified new pathways for research. Researchers at the Icahn School of Medicine at Mount Sinai have achieved a major breakthrough in Alzheimer's disease research. Their study identifies a promising method that could potentially slow or even stop the p

This study focuses on the manipulation of the plexin-B1 protein to enhance the brain’s ability to clear amyloid plaques in Alzheimer’s disease, opening avenues for future therapeutic strategies to potentially halt the progression of the disease

https://www.nature.com/articles/s41593-024-01664-w